ArticleNeoplasia (New York, N.Y.)2013

Synthetic lethality screen identifies RPS6KA2 as modifier of epidermal growth factor receptor activity in pancreatic cancer.

Nada Milosevic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.